PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France.\', \'Perception and Memory Unit, Institut Pasteur, CNRS UMR 3571, Paris, France.\', \'Biomics Technological Platform, Center for Technological Resources and Research (C2RT), Institut Pasteur, Paris, France.\', \'Bioinformatics and Biostatistics Hub, Computational Biology Department, Institut Pasteur, Paris, France.\', \'Biology of Infection Unit, Institut Pasteur, Inserm U1117, Paris, France.\', \'Nuclear Organization and Oncogenesis Unit, Institut Pasteur, Paris, France.\', \'Experimental Neuropathology Unit, Institut Pasteur, Paris, France.\', \'Division of Infectious Diseases and Tropical Medicine, Institut Imagine, Université de Paris, Necker-Enfants Malades University Hospital, AP-HP, Paris, France.\', \'Neuroscience Department, Institut Pasteur, Collège de France, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15252/emmm.202114122
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 34170074
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34170074>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34170074>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all